X

Health Care

Onconova Therapeutics cuts down losses in 2018

Onconova Therapeutics (ONTX), a Phase 3 biopharmaceutical company that focuses on developing cancer drugs, Tuesday posted a narrowed loss in…

Earnings Preview: Aeterna Zentaris reporting Q4 results on Mar 26

Aeterna Zentaris (AEZS) is scheduled to report its fourth-quarter financial results on March 26, Tuesday, after the regular trading hours.…

Canopy Growth accelerates US expansion plans with AgriNextUSA acquisition

The world’s largest cannabis company by market cap, Canopy Growth Corporation (CGC), on Thursday said it was acquiring US-based hemp…

What is NASH and which biotech firms are vying for the first-mover status

NASH, or Nonalcoholic steatohepatitis, is undeniably a golden goose in the pharma space. The biggest corporate attraction towards this liver…

Aurinia’s loss widened to $14.6 million in Q4 2018

Aurinia Pharmaceuticals (NASDAQ: AUPH/TSX: AUP) reported its fourth quarter and full-year 2018 results after the bell today. The company reported…

Catalyst Pharma loss widens in Q4 due to Firdapse launch

Catalyst Pharmaceuticals (Nasdaq: CPRX) reported a loss of $0.14 per share compared to $0.12 loss expected by the street. The…

Dermira stock doubles and hits new 52-week high on positive eczema trial results

Dermira Inc. (DERM) announced positive results from Phase 2b study for treating patients with atopic dermatitis, a condition which causes…

Axsome Therapeutics stock climbs to 34-month high

After the slump on weak quarterly results, investors turned positive on Axsome Therapeutics (AXSM) stock, which climbed to the 34-month…

NASH drug developer Genfit plans $132-million US IPO, to list on Nasdaq

France-based biopharmaceutical firm Genfit (EPA: GNFT) has launched a global offering of its American Depository Shares and ordinary shares to…

Novavax misses Q4 estimates, shares slip

NVAX Earnings Transcripts    NVAX Earnings Calendar Clinical-stage vaccine company Novavax (NVAX) reported a loss of 13 per share in…